BAXTER INTERNATIONAL INC 8K

Baxter International Inc. announced better‑than‑expected Q2 2026 results and raised its full‑year 2026 sales and adjusted EPS guidance while implementing an updated segment reporting structure and publishing its 2025 Sustainability Report with new targets.

Baxter International Inc. reported its second-quarter 2026 results, highlighting 5% reported and organic sales growth to $2.96 billion, U.S. GAAP diluted EPS of $0.26 and adjusted diluted EPS of $0.56, driven by growth across all segments and aided by an $0.11 per-share IEEPA tariff refund, while noting that adjusted EPS declined 5% year-over-year due to higher-cost 2025 inventory and prior-year cost reclassifications. The company updated its segment reporting structure beginning in Q2 2026 to reflect its new operating model, with all segments and divisions delivering growth in both U.S. and international markets. Baxter also published its 2025 Sustainability Report with refreshed sustainability targets and raised its full-year 2026 financial outlook, now expecting 3–4% reported sales growth (up from flat to 1%), 2–3% organic sales growth (up from approximately flat), and adjusted diluted EPS of $1.95–$2.15 (up from $1.85–$2.05). Management emphasized ongoing efforts under the Baxter Growth and Performance System to stabilize the business, strengthen the balance sheet, and drive continuous improvement, supported by free cash flow of $181 million in the quarter and $257 million year-to-date.

Filing Facts

CIK

10456

Ticker

BAX

Form

8K

Source Type

fda

Accession

0001628280-26-050795

Alert Tier

7